Juno Pharmaceuticals settles trade mark dispute with Juno Therapeutics

Biopharmalex 2019-01-25 3:42 pm By Miklos Bolza | Sydney

Please login to bookmark

Juno Pharmaceuticals has resolved its appeal of an IP Australia ruling that allowed Seattle-based Juno Therapeutics to extend protection of its namesake trade mark into Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au